TSMR.F Stock Overview
Tsumura & Co. fabrica y vende productos farmacéuticos en todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Tsumura & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥25.86 |
| 52 Week High | JP¥25.86 |
| 52 Week Low | JP¥18.10 |
| Beta | 0.19 |
| 1 Month Change | 11.47% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -24.71% |
| 5 Year Change | n/a |
| Change since IPO | 34.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| TSMR.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | -0.8% |
| 1Y | n/a | 16.6% | 25.9% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de TSMR.F en comparación con el sector US Pharmaceuticals .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de TSMR.F frente al mercado US.
Price Volatility
| TSMR.F volatility | |
|---|---|
| TSMR.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: TSMR.Fha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de TSMR.F en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 4,032 | Terukazu Kato | https://www.tsumura.co.jp |
Tsumura & Co. fabrica y vende productos farmacéuticos en todo el mundo. La empresa ofrece productos intermedios de extracto de Kampo y formulaciones granuladas de Kampo. Se dedica a la adquisición, selección y procesamiento, y almacenamiento de materias primas de medicamentos crudos y trozos de medicamentos crudos para decocción; fabricación de extractos en polvo de Kampo y medicinas tradicionales chinas; y venta de productos farmacéuticos y alimentarios.
Tsumura & Co. Fundamentals Summary
| TSMR.F fundamental statistics | |
|---|---|
| Market cap | US$1.91b |
| Earnings (TTM) | US$110.40m |
| Revenue (TTM) | US$980.22m |
17.8x
P/E Ratio2.0x
P/S RatioIs TSMR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSMR.F income statement (TTM) | |
|---|---|
| Revenue | JP¥148.79b |
| Cost of Revenue | JP¥78.01b |
| Gross Profit | JP¥70.78b |
| Other Expenses | JP¥54.02b |
| Earnings | JP¥16.76b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 220.71 |
| Gross Margin | 47.57% |
| Net Profit Margin | 11.26% |
| Debt/Equity Ratio | 26.8% |
How did TSMR.F perform over the long term?
See historical performance and comparison